These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

369 related items for PubMed ID: 11180396

  • 1. Transformation by H-ras can result in aberrant regulation of ornithine decarboxylase gene expression by transforming growth factor-beta(1).
    Hurta RA, Lee J, Voskas D.
    J Cell Biochem; 2001; 81(1):39-55. PubMed ID: 11180396
    [Abstract] [Full Text] [Related]

  • 2. Tumour promoter mediated altered expression and regulation of ornithine decarboxylase and S-adenosylmethionine decarboxylase in H-ras-transformed fibrosarcoma cell lines.
    Voskas D, Mader R, Lee J, Hurta RA.
    Biochem Cell Biol; 2001; 79(1):69-81. PubMed ID: 11235918
    [Abstract] [Full Text] [Related]

  • 3. Transforming growth factor beta 1 selectively regulates ornithine decarboxylase gene expression in malignant H-ras transformed fibrosarcoma cell lines.
    Hurta RA, Greenberg AH, Wright JA.
    J Cell Physiol; 1993 Aug; 156(2):272-9. PubMed ID: 8344985
    [Abstract] [Full Text] [Related]

  • 4. Malignant transformation by H-ras results in aberrant regulation of ribonucleotide reductase gene expression by transforming growth factor-beta 1.
    Hurta RA, Wright JA.
    J Cell Biochem; 1995 Mar; 57(3):543-56. PubMed ID: 7768988
    [Abstract] [Full Text] [Related]

  • 5. Transforming growth factor beta1 selectively regulates ferritin gene expression in malignant H-ras-transformed fibrosarcoma cell lines.
    Lo J, Hurta RA.
    Biochem Cell Biol; 2000 Mar; 78(4):527-35. PubMed ID: 11012093
    [Abstract] [Full Text] [Related]

  • 6. Ornithine decarboxylase gene expression is aberrantly regulated via the cAMP signal transduction pathway in malignant H-ras transformed cell lines.
    Hurta RA, Wright JA.
    J Cell Physiol; 1994 Nov; 161(2):383-91. PubMed ID: 7525612
    [Abstract] [Full Text] [Related]

  • 7. Regulation of transforming growth factor beta receptors in H-ras oncogene-transformed rat intestinal epithelial cells.
    Zhao J, Buick RN.
    Cancer Res; 1995 Dec 15; 55(24):6181-8. PubMed ID: 8521411
    [Abstract] [Full Text] [Related]

  • 8. Transforming growth factor-beta 1 mediated alterations in ribonucleotide reductase gene expression in BALB/c 3T3 fibroblasts.
    Hurta RA, Greenberg AH, Wright JA.
    J Cell Physiol; 1992 Sep 15; 152(3):529-35. PubMed ID: 1506411
    [Abstract] [Full Text] [Related]

  • 9. Restored expression of transforming growth factor beta type II receptor in k-ras-transformed thyroid cells, TGF beta-resistant, reverts their malignant phenotype.
    Coppa A, Mincione G, Lazzereschi D, Ranieri A, Turco A, Lucignano B, Scarpa S, Ragano-Caracciolo M, Colletta G.
    J Cell Physiol; 1997 Aug 15; 172(2):200-8. PubMed ID: 9258341
    [Abstract] [Full Text] [Related]

  • 10. Anti-tumor activity of antizyme which targets the ornithine decarboxylase (ODC) required for cell growth and transformation.
    Iwata S, Sato Y, Asada M, Takagi M, Tsujimoto A, Inaba T, Yamada T, Sakamoto S, Yata J, Shimogori T, Igarashi K, Mizutani S.
    Oncogene; 1999 Jan 07; 18(1):165-72. PubMed ID: 9926931
    [Abstract] [Full Text] [Related]

  • 11. Ornithine decarboxylase induction in transformation by H-Ras and RhoA.
    Shantz LM, Pegg AE.
    Cancer Res; 1998 Jul 01; 58(13):2748-53. PubMed ID: 9661886
    [Abstract] [Full Text] [Related]

  • 12. c-Myc induces the expression and activity of ornithine decarboxylase.
    Wagner AJ, Meyers C, Laimins LA, Hay N.
    Cell Growth Differ; 1993 Nov 01; 4(11):879-83. PubMed ID: 8297793
    [Abstract] [Full Text] [Related]

  • 13. Transforming growth factor (TGF)-beta in conjunction with H-ras activation promotes malignant progression of MCF10A breast epithelial cells.
    Kim ES, Kim MS, Moon A.
    Cytokine; 2005 Jan 21; 29(2):84-91. PubMed ID: 15598443
    [Abstract] [Full Text] [Related]

  • 14. Induction of ornithine decarboxylase by IL-3 is mediated by sequential c-Myc-independent and c-Myc-dependent pathways.
    Packham G, Cleveland JL.
    Oncogene; 1997 Sep 04; 15(10):1219-32. PubMed ID: 9294616
    [Abstract] [Full Text] [Related]

  • 15. Transforming growth factor beta 1 partially suppresses the transformed phenotype of ras-transformed hepatocytes.
    Serra R, Verderame MF, Isom HC.
    Cell Growth Differ; 1992 Oct 04; 3(10):693-704. PubMed ID: 1332741
    [Abstract] [Full Text] [Related]

  • 16. A cis-trans interaction at the 3'-untranslated region of ribonucleotide reductase mRNA is regulated by TGF-beta 1, TGF-beta 2, and TGF-beta 3.
    Amara FM, Smith GM, Kuschak TI, Takeuchi TL, Wright JA.
    Biochem Biophys Res Commun; 1996 Nov 12; 228(2):347-51. PubMed ID: 8920917
    [Abstract] [Full Text] [Related]

  • 17. Transformation of NIH/3T3 cells by ornithine decarboxylase overexpression.
    Moshier JA, Dosescu J, Skunca M, Luk GD.
    Cancer Res; 1993 Jun 01; 53(11):2618-22. PubMed ID: 8495425
    [Abstract] [Full Text] [Related]

  • 18. Basic fibroblast growth factor selectively regulates ornithine decarboxylase gene expression in malignant H-ras transformed cells.
    Hurta RA, Huang A, Wright JA.
    J Cell Biochem; 1996 Mar 15; 60(4):572-83. PubMed ID: 8707896
    [Abstract] [Full Text] [Related]

  • 19. Loss of transforming growth factor beta 1 (TGF-beta 1)-induced growth arrest and p34cdc2 regulation in ras-transfected epithelial cells.
    Longstreet M, Miller B, Howe PH.
    Oncogene; 1992 Aug 15; 7(8):1549-56. PubMed ID: 1630817
    [Abstract] [Full Text] [Related]

  • 20. Regulation of ornithine decarboxylase in a transformed cell line that overexpresses translation initiation factor eIF-4E.
    Shantz LM, Hu RH, Pegg AE.
    Cancer Res; 1996 Jul 15; 56(14):3265-9. PubMed ID: 8764119
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 19.